Respiratory Medicine
Volume 96, Supplement 2 , Pages S31-S35, April 2002

Development of a potent respiratory syncytial virus-specific monoclonal antibody for the prevention of serious lower respiratory tract disease in infants

  • J. YOUNG

      Affiliations

    • Research and Development, MedImmune Inc. Gaithersburg, MD, U.S.A.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0954-6111(02)91298-9

doi:10.1053/rmed.2002.1298

Respiratory Medicine
Volume 96, Supplement 2 , Pages S31-S35, April 2002

Article Tools